Intellectual Property / Telecoms, Media and Technology

_Wildgen’s IP/TMT Practice Group helps clients to protect and develop their core business in compliance with the latest regulations.

Our expert lawyers assist with both contentious and non-contentious IP/TMT issues. They advise clients at every important stage of their strategy and handle high-value, multi-jurisdictional transactional, advisory and litigation work. Thanks to our excellent success rate for IP/TMT litigation cases to date, our team can assess the probable outcome of litigation and provide a risk-managed approach. It can also advise on the best preventative actions and the most efficient ways to protect clients’ assets.

OUR SERVICES

With the support of our finance, tax and corporate lawyers, the IP/TMT Practice Group offers the most comprehensive services to its clients. In addition to the advisory aspect, we represent clients not only before the Luxembourg courts, but also before the European Court of Justice (CJEU), the Benelux Office for Intellectual Property (BOIP) and the European Union Intellectual Property Office (EUIPO).

OUR CLIENTS

From start-ups to international companies, our clients include professionals across a variety of industry sectors such as financial services, pharmaceuticals, healthcare, energy, automotive, technology and creatives.

Recent transactions include:

• For a Luxembourg-based studio: Successful counteracting of the introduction to the market of a contactless control screen that strongly looked like our client’s product by an electronics giant and a multinational automotive manufacturing company.
• For a leading American shoe company: Defence of the client’s IP rights regarding counterfeit products and successful representation through specific procedures before national courts.
• For a leading cybersecurity company in Luxembourg and Belgium: Legal assistance on trademark acquisitions, M&A transactions, group restructuring and recapitalisation, employment law, unfair competition and ongoing negotiations with investors.
• For an independent EU ophthalmology group: Acquisition of IP rights, licence agreements and commercial exploitation rights for a number of pharmaceuticals from a top multinational pharmaceutical company.

OUR EDGE

		Leading firm in IP/TMT by international rankings
		High success rate for IP/TMT litigation
		One-stop-shop assistance
		Cutting-edge expertise
		Creative and pragmatic solutions
		Timely and accurate services

 ACCOLADES
 

Wildgen is ranked Tier 2 for IP and IT by Legal 500.